Thymosin Alpha 1 will help Covid patients recover quickly: Specialist doctors

Bengaluru: Critical care specialists recommend Thymosin Alpha 1, a new therapy in helping Covid-19 patients recover quickly and bring down the mortality rate.

A new therapy that has come to the rescue of Covid-19 affected patients is Thymosin Alpha 1, a drug molecule named as Immunocin Alpha 1 that has been able to modulate the immune system and has helped a lot of patients across India.

The treating physician decides the dose of Immunocin Alpha 1 depending on severity of patients Covid-19 symptoms. The treatment duration is seven days. The drug has been well tolerated without any adverse effects.

It has been observed that patients with co-morbidities are highly susceptible to the Covid-19 infection. This patient population has also presented as a high-risk group with a high mortality rate throughout the world. Immunocin Alpha 1 has shown benefit in treatment of Covid-19 patients with comorbid conditions like diabetes, hypertension, chronic kidney disease and also in elderly patients.

Thymosin Alpha 1 has a history of treatment of diseases in which the immunity is dysregulated like hepatitis, AIDS and SARS. As Covid-19 is a disease which primarily attacks the immune system of an individual. Thymosin Alpha 1 has been proven by research studies to be a safe and effective medication in treatment of Covid-19.

Dr R. Ravi Kumar, Consultant Intensivist and Head ICU & Critical Care, Sagar Group of Hospitals, Bengaluru, said "Immunocin Alpha 1 reduces cytokine storm & ultimately reduces mortality of severe Covid-19 by restoration of lymphocytopenia & reversion of exhausted T cells. Till date, I have used this molecule in approximately over 200 patients who have benefited that I have personally monitored."

"Patients who sought early medical help, were definitely benefited by Thymosin Alpha 1 as, we could manage them with HFNC, they never needed intubation & mechanical ventilation. I have used it on mild to moderate cases as well and this helped the patients to prevent invasive ventilation. The basic treatment remains the same that has been there for Covid-19 patients but Thymosin Alpha 1 is used as adjuvant therapy. Also, this has to be given under the supervision of critical care specialists," he elaborated.